Opportunity Information: Apply for RFA IP 11 009
Apply for RFA IP 11 009
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician Gynecologist Setting" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Jan 5, 2011 and posted on Jan 5, 2011.
- Applicants must submit their applications by Apr 12, 2011 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM Eastern Time. Note.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, RFA IP 11 009 from the Centers for Disease Control and Prevention (CDC), supports a single cooperative agreement aimed at improving vaccination delivery in obstetrician-gynecologist (OB-GYN) clinical settings. The central focus is to evaluate how well a specific intervention works in helping OB-GYN practices start and sustain an in-office vaccination program for three priority vaccines: human papillomavirus (HPV), seasonal influenza, and tetanus, diphtheria, and acellular pertussis (Tdap). In practical terms, the grant is designed to move beyond general education or awareness and instead build and test real-world strategies that make it easier for OB-GYN clinicians and their teams to routinely offer and administer these vaccines as part of standard patient care.
The purpose of the project is twofold: development and evaluation. Applicants are expected to develop strategies or tools that address common barriers to vaccination within OB-GYN practices, and then evaluate whether those strategies actually lead to measurable improvements in a practice's ability to initiate and maintain a targeted vaccination program. The CDC frames "progress" as evidence that the intervention helps practices both get a program off the ground and keep it operating over time, suggesting an emphasis on implementation success and sustainability rather than a one-time campaign. Because this is a cooperative agreement, the CDC is likely to anticipate substantial involvement with the awardee during the project period, such as collaboration on the intervention design, evaluation approach, or dissemination of findings, although the specific level of involvement would be detailed in the full announcement.
From an administrative standpoint, this is a discretionary health grant under CFDA 93.185 (Immunization Research, Demonstration, Public Information and Education; Training and Clinical Skills Improvement Projects). The opportunity anticipated one award, with an award ceiling of $300,000 and no cost-sharing or matching requirement, meaning applicants were not required to contribute non-federal funds to be eligible. Eligibility is described as unrestricted, indicating that a wide range of entity types could apply (for example, universities, nonprofits, health systems, professional associations, or other organizations), subject to any additional eligibility clarifications that may have been included in the full FOA text.
The posting and timeline information shows the opportunity was posted on January 5, 2011, with an original and current closing date of April 12, 2011, and an archive date of May 12, 2011. Applications had to be submitted electronically through Grants.gov and successfully validated in Grants.gov and eRA Commons by 5:00 PM Eastern Time on the deadline date. The notice also emphasizes a strict submission policy: CDC/HHS procedures did not provide an error-correction window after the deadline, so applications needed to be error-free and fully validated by the cutoff time to be considered on time.
Overall, the grant can be understood as CDC support for a practice-based implementation and evaluation effort that strengthens immunization delivery where many women routinely receive care. By targeting HPV, influenza, and Tdap, the FOA highlights vaccines with strong public health importance and relevance to OB-GYN patients, and it positions OB-GYN practices as key access points for increasing vaccination uptake through reliable, sustained in-clinic programs. For technical assistance or access issues with the full announcement, the listed contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700.
Frequently Asked Questions (FAQs): CDC RFA IP 11 009 (Improving Vaccination Delivery in OB-GYN Settings)
1) What is this funding opportunity?
This opportunity is CDC RFA IP 11 009, a discretionary health grant that funds a single cooperative agreement focused on improving how vaccinations are delivered in obstetrician-gynecologist (OB-GYN) clinical settings.
2) What is the main goal of the project?
The central goal is to evaluate how well a specific intervention helps OB-GYN practices start and sustain an in-office vaccination program as part of routine patient care.
3) Which vaccines are the focus of the program?
The project targets three priority vaccines: human papillomavirus (HPV), seasonal influenza, and tetanus, diphtheria, and acellular pertussis (Tdap).
4) Is this grant mainly for education and awareness campaigns?
No. The description emphasizes moving beyond general education or awareness. The intent is to build and test real-world strategies that make it easier for OB-GYN clinicians and staff to routinely offer and administer vaccines in the clinic.
5) What are applicants expected to do under this project?
Applicants are expected to do two major things: (1) develop strategies or tools that address common barriers to vaccination within OB-GYN practices, and (2) evaluate whether those strategies lead to measurable improvements in a practice's ability to initiate and maintain a targeted vaccination program over time.
6) What does CDC mean by "progress" in this opportunity?
Progress is framed as evidence that an intervention helps OB-GYN practices both get an in-office vaccination program off the ground and keep it operating over time. The emphasis is on implementation success and sustainability, not a one-time effort.
7) What kind of award is this?
This is a cooperative agreement. That generally indicates substantial CDC involvement during the project period, potentially including collaboration on intervention design, evaluation approach, and dissemination of findings (the specific details would be described in the full announcement).
8) How many awards did CDC anticipate making?
CDC anticipated making one award.
9) What is the maximum funding amount (award ceiling)?
The award ceiling listed is $300,000.
10) Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
11) What is the CFDA number for this grant?
The CFDA is 93.185, titled "Immunization Research, Demonstration, Public Information and Education; Training and Clinical Skills Improvement Projects."
12) Who is eligible to apply?
Eligibility is described as unrestricted, meaning a wide range of entity types could apply (for example, universities, nonprofits, health systems, professional associations, or other organizations), subject to any additional eligibility clarifications that may have been included in the full FOA text.
13) When was the opportunity posted?
The opportunity was posted on January 5, 2011.
14) What was the application deadline?
The closing date (original and current) was April 12, 2011.
15) When was the opportunity archived?
The archive date was May 12, 2011.
16) How did applicants have to submit their applications?
Applications had to be submitted electronically through Grants.gov.
17) What systems had to validate the application by the deadline?
The application had to be successfully validated in both Grants.gov and eRA Commons by the deadline time to be considered on time.
18) What was the exact deadline time for validation?
Applications needed to be submitted and successfully validated by 5:00 PM Eastern Time on the deadline date.
19) Was there an error-correction window after the deadline?
No. The notice states CDC/HHS procedures did not provide an error-correction window after the deadline. Applications needed to be error-free and fully validated by the cutoff time.
20) What types of results does this funding opportunity seem to prioritize?
Based on the description, the opportunity prioritizes practical implementation and evaluation results that demonstrate an OB-GYN practice can reliably offer and administer HPV, influenza, and Tdap vaccines through a sustained in-clinic program.
21) Why focus on OB-GYN practices for vaccination delivery?
The opportunity positions OB-GYN practices as key access points for increasing vaccination uptake because many women routinely receive care in these settings. The intent is to strengthen immunization delivery where patients are already engaged in ongoing clinical care.
22) Who was the listed contact for technical assistance or access issues?
The listed contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
23) What phone number was provided for the CDC contact?
The phone number provided was 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: National Park Service yellowstone Archaeology Technical Assistance Project
Previous opportunity: Theodore Roosevelt Inaugural Site Operations and Management
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 11 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 11 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Center for Chronic Disease Prevention and Health Promotion Conference Support Program Apply for CDC RFA DP11 1102 Funding Number: CDC RFA DP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Genomic Resource Grants for Community Resource Projects (U41) Apply for PAR 11 095 Funding Number: PAR 11 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhanced Surveillance for New Vaccine Preventable Disease Apply for RFA IP 11 010 Funding Number: RFA IP 11 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Affordable Care Act Health Center Planning Grants Apply for HRSA 11 021 Funding Number: HRSA 11 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States Apply for RFA IP 11 003 Funding Number: RFA IP 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $785,000 |
| Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools. Apply for RFA IP 11 006 Funding Number: RFA IP 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Economic Studies of Vaccines and Immunization Policies, Programs and Practices Apply for RFA IP 11 007 Funding Number: RFA IP 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Incidence and Etiology of Influenza Associated Community Acquired Pneumonia in Hospitalized Persons Study Apply for RFA IP 11 011 Funding Number: RFA IP 11 011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH11 1105 Funding Number: CDC RFA EH11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Service Area Competition Additional Areas Apply for HRSA 11 163 Funding Number: HRSA 11 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Delta Health Initiative Apply for HRSA 11 090 Funding Number: HRSA 11 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition A Consortium to Study Genetics of Longevity (U19) Apply for PAR 11 101 Funding Number: PAR 11 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| EIS Ongoing Expansion Funds for Current Part C Grantees Apply for HRSA 11 092 Funding Number: HRSA 11 092 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| Ethiopia Comprehensive HIV AIDS Treatement Care and Support Program Apply for RFA 663 11 000005 Funding Number: RFA 663 11 000005 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $42,000,000 |
| Pediatric Device Consortia Grant Program (P50) Apply for RFA FD 11 002 Funding Number: RFA FD 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Programs to Improve the Health and Educational Outcomes of Young People Apply for CDC RFA DP11 1101 Funding Number: CDC RFA DP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Implementation of Programs to Improve Quality Laboratory Services in support of HIV/AIDS Care, Support and Treatment at the University Teaching Hospital Antiretroviral Clinic and Laboratory in the Republic of Zambia under PEPFAR Apply for CDC RFA GH11 1121 Funding Number: CDC RFA GH11 1121 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the National Reference Laboratory to Perform and Oversee Laboratory Services in Rwanda under the President s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Initiative Apply for CDC RFA GH11 1163 Funding Number: CDC RFA GH11 1163 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Free Communities Support Program Apply for SP 11 002 Funding Number: SP 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Capacity Building and Sustainability to Strengthen the Epidemiology and Laboratory Management Public Health Infrastructure of the Republic of Angola Apply for CDC RFA GH11 1186 Funding Number: CDC RFA GH11 1186 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 11 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.